Serum complement (C3, C4) levels in patients with acute myocardial infarction and angina pectoris.
dc.contributor.author | Giasuddin, A S M | en_US |
dc.contributor.author | ElMahdawi, Jamila M | en_US |
dc.contributor.author | ElHassadi, Fakhri M | en_US |
dc.date.accessioned | 2007-12-12 | en_US |
dc.date.accessioned | 2009-05-27T03:47:00Z | |
dc.date.available | 2007-12-12 | en_US |
dc.date.available | 2009-05-27T03:47:00Z | |
dc.date.issued | 2007-12-12 | en_US |
dc.description | Bangladesh Medical Research Council Bulletin. | en_US |
dc.description.abstract | Serum complement (C3, C4) levels in Libyan patients with acute myocardial infarction (AMI; 31 patients) and angina pectoris (AP; 11 patients) at the 1st day and 7th day of attack were estimated. A group of 26 healthy Libyans were taken as control subjects (CS). Serum C3 and C4 levels (mean +/- SD, mg/dl) were elevated at the 1st day in AMI as well as AP patients (C3 --> AMI1: 154.0 +/- 28.5, AP1: 152.0 +/- 45.0, CS: 132.0 +/- 8.0, ANOVA: p = 0.0072; C4 --> AMII1: 38 +/- 13, AP1: 37 +/- 17, CS: 29 +/- 6, ANOVA: p = 0.0160). No significant differences for the elevated C3 and C4 levels at the 1st day were observed between the two diseases groups (AMI1 vs AP1 --> C3: p = 0.879, C4: p = 0.818). At the 7th day, C3 and C4 levels were further elevated in AMI, while they remained at the similar elevated levels in AP (C3 --> AMI 7: 173.1 +/- 28.0, AP 7: 149.0 +/- 41.0, CS: 132.0 +/- 8.0, ANOVA: p = 0.0000; C4 --> AMI 7: 46.0 +/- 7.0, AP 7: 36.0 +/- 15.0, CS: 29.0 +/- 6.0, ANOVA: p = 0.0000). Again, no significance differences for the raised C3 and C4 levels at the 7th day was observed between AMI and AP patients (AMI 7 vs AP 7 --> C3: P = 0.059, C4: p = 0.06). The C3 elevation showed significant positive correlation in AMI group (r = 0.522, p = 0.003) while it was insignificant in AP patients (r = 0.037, p = 0.915). Regarding C4 levels, it was significantly correlated in AMI (r = 0.483, p = 0.006), and in AP, although it was positively correlated (r = 0.656, P = 0.028) the observed difference was not significant (t = 0.29, p = 0.778). In conclusion, serum C3 and C4 levels were more profoundly elevated in AMI compared to AP patients suggestive of an acute phase and inflammatory response. | en_US |
dc.description.affiliation | Department of Laboratory Medicine, Al-Arab Medical University, Benghazi, Libya. asmgias@proshikanet.com | en_US |
dc.identifier.citation | Giasuddin AS, ElMahdawi JM, ElHassadi FM. Serum complement (C3, C4) levels in patients with acute myocardial infarction and angina pectoris. Bangladesh Medical Research Council Bulletin. 2007 Dec; 33(3): 98-102 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/219 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.banglajol.info/index.php/BMRCB/index | en_US |
dc.source.uri | https://www.banglajol.info/index.php/BMRCB/article/view/1141/1153 | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Aged, 80 and over | en_US |
dc.subject.mesh | Angina Pectoris --blood | en_US |
dc.subject.mesh | Case-Control Studies | en_US |
dc.subject.mesh | Complement C3 --analysis | en_US |
dc.subject.mesh | Complement C4 --analysis | en_US |
dc.subject.mesh | Complement Hemolytic Activity Assay | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Health Surveys | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Libya | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Myocardial Infarction --blood | en_US |
dc.subject.mesh | Questionnaires | en_US |
dc.subject.mesh | Risk Factors | en_US |
dc.title | Serum complement (C3, C4) levels in patients with acute myocardial infarction and angina pectoris. | en_US |
dc.type | Journal Article | en_US |
dc.type | Research Support, Non-U.S. Gov't | en_US |